Skip to main content
Caplight Logo









Allgenesis Biotherapeutics Inc.

Allgenesis Biotherapeutics Inc.

Private
TaipeiHealthcare & Life Scienceshttps://www.allgenesis.com/

Company Overview

Allgenesis Biotherapeutics Inc. is a biopharmaceutical company that focuses on the research and development of novel ophthalmic medicines for the treatment of eye diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

ophthalmic therapiesbiopharmaceuticalretinal diseasesbi-specific fusion proteindrug discoveryclinical-stage biotechdry eye diseasediabetic macular edemaDMEneovascular age-related macular degenerationnAMDtyrosine kinase inhibitordrug licensingophthalmology pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allgenesis Biotherapeutics Inc. Comparables

Compare Allgenesis Biotherapeutics Inc. with similar companies based on industry and business-model similarity.

Allgenesis Biotherapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Memento Medicines
83%
MabTics Co., Ltd.
82%
INGENIA Therapeutics
82%

Allgenesis Biotherapeutics Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Madhu Cherukury

Chief Executive Officer

Executive Team

Allgenesis Biotherapeutics Inc. Filings

Explore SEC and related filing metadata, where available.

Allgenesis Biotherapeutics Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Allgenesis Biotherapeutics Inc.'s valuation, stock price, and market status.

Is Allgenesis Biotherapeutics Inc. a public or private company?

Allgenesis Biotherapeutics Inc. is a private company.

What is the current stock price of Allgenesis Biotherapeutics Inc.?

Allgenesis Biotherapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Allgenesis Biotherapeutics Inc. worth (valuation)?

Valuation information for Allgenesis Biotherapeutics Inc. is not publicly available.

Can I buy Allgenesis Biotherapeutics Inc. stock?

Allgenesis Biotherapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Allgenesis Biotherapeutics Inc.'s last funding round?

Funding round information for Allgenesis Biotherapeutics Inc. is not publicly available.

Who are the main investors in Allgenesis Biotherapeutics Inc.?

Investor information for Allgenesis Biotherapeutics Inc. is not publicly disclosed.

Will Allgenesis Biotherapeutics Inc. IPO soon?

No public IPO plans have been announced for Allgenesis Biotherapeutics Inc..

How can I track Allgenesis Biotherapeutics Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allgenesis Biotherapeutics Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTaipei
Employee Range4
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?